Multidrug resistant Acinetobacter baumannii reaches a new frontier: prosthetic hip joint infection

Acinetobacter baumannii is an emerging nosocomial pathogen primarily in countries with a high prevalence of multidrug resistance. Here we report the detection of a bla OXA23 carbapenemase-producing A. baumannii strain in a German patient with prosthetic hip joint infection following several hip join...

Full description

Saved in:
Bibliographic Details
Published in:Infection 2015-02, Vol.43 (1), p.95-97
Main Authors: Hischebeth, G. T. R., Wimmer, M. D., Molitor, E., Seifert, H., Gravius, S., Bekeredjian-Ding, I.
Format: Article
Language:English
Subjects:
Acinetobacter baumannii
Acinetobacter baumannii - drug effects
Acinetobacter baumannii - isolation & purification
Acinetobacter Infections
Adult
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Case Report
Drug Resistance, Multiple, Bacterial
Family Medicine
General Practice
Hip Prosthesis - adverse effects
Humans
Infectious Diseases
Internal Medicine
Male
Medicine
Medicine & Public Health
Nosocomial infection
Prosthesis-Related Infections
Reoperation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acinetobacter baumannii is an emerging nosocomial pathogen primarily in countries with a high prevalence of multidrug resistance. Here we report the detection of a bla OXA23 carbapenemase-producing A. baumannii strain in a German patient with prosthetic hip joint infection following several hip joint surgeries but no history of foreign travel.
ISSN:0300-8126
1439-0973
DOI:10.1007/s15010-014-0661-x